The absolute risk of seizures with carbapenems overall appears to be low, with imipenem having the highest propensity. One retrospective study in older adults significantly correlated carbapenem-induced seizure in patients with a history of seizures; however, this study also found imipenem to have the lowest incidence of seizures (Table 1). Available data suggest benzodiazepines as an option for carbapenem-associated seizures.
Carbapenems’ known ability to cause seizures may be directly tied to their beta-lactam ring structure, which is similar enough to gamma-aminobutyric acid (GABA) to antagonize central GABA receptors. Individual carbapenems and seizure activity data are sparse. A literature search of the MEDLINE (1966-May 2010), EMBASE (1974-May 2010), and International Pharmaceutical Abstracts (1970-May 2010) databases was conducted to determine the existing evidence on the connection between carbapenem agents and seizure activity. There have been multiple instances of seizures linked to imipenem-cilastatin, with seizure rates ranging from 3 to 33%. The seizure rate for meropenem, doripenem, and ertapenem is stated to be less than 1%. However, as their usage grows and expands into new patient populations, the rate of seizures associated with these drugs may rise. High-dose therapy also increases the chance of seizure activity, especially in patients with renal impairment, prior central nervous system...
READ MORE→
A search of the published medical literature revealed
2 studies investigating the researchable question:
What is the comparative safety profile of individual carbapenems, specifically meropenem, imipenem, and doripenem, in patients with a history of seizures?
Level of evidence
C - Multiple studies with limitations or conflicting results
READ MORE→
[1] Miller AD, Ball AM, Bookstaver PB, Dornblaser EK, Bennett CL. Epileptogenic potential of carbapenem agents: mechanism of action, seizure rates, and clinical considerations. Pharmacotherapy. 2011;31(4):408-423. doi:10.1592/phco.31.4.408
[2] Cannon JP, Lee TA, Clark NM, Setlak P, Grim SA. The risk of seizures among the carbapenems: a meta-analysis. J Antimicrob Chemother. 2014;69(8):2043-2055. doi:10.1093/jac/dku1111
[3] Wanleenuwat P, Suntharampillai N, Iwanowski P. Antibiotic-induced epileptic seizures: mechanisms of action and clinical considerations. Seizure. 2020;81:167-174. doi:10...